| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases |
| 05/16/2002 | US20020058664 Beta-amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 |
| 05/16/2002 | US20020058662 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/16/2002 | US20020058653 Administering cyclic polyamine compound to elevate white blood cell (WBC) count |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058615 Endothelial specific targeting |
| 05/16/2002 | US20020058614 Especially administered by direct injection into the afflicted cartilagenous region or joint. |
| 05/16/2002 | US20020058284 Methods and compositions for treating macrophage-mediated diseases |
| 05/16/2002 | US20020058066 Outer layer portion containing cilostazol, a water-insoluble substance, such as ethyl cellulose, and a hydrophilic hydrogel forming substance, such as hydroxypropyl methyl cellulose. |
| 05/16/2002 | US20020058048 Contains a nonionic, amphoteric or cationic surfactant in an amount effective to eliminate or substantially ameliorate burning pain caused by capsaicin. |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
| 05/16/2002 | US20020056827 Piezoelectric element and process for production thereof |
| 05/16/2002 | DE10056136A1 Inhibiting leukocyte or tumor cell adhesion to vascular endothelial cells e.g. for combating inflammation or metastasis, using e.g. pregnancy proteins or selectin binding liposomes containing calcium-binding compound |
| 05/16/2002 | DE10054294A1 Topische Behandlung bei der Mastalgie Topical treatment of mastalgia |
| 05/16/2002 | DE10053053A1 Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden Pharmaceutical formulations for inhibition of inflammatory arthritis |
| 05/16/2002 | CA2428176A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | CA2428164A1 Method for the treatment of inflammation |
| 05/16/2002 | CA2428141A1 Use of selectin-binding pregnancy proteins, liposomes, native mucin fragments and mimetic compounds for the treatment and prophylaxis of inflammatory diseases, for preventing metastatic spread and for the prophylaxis of tumour diseases |
| 05/16/2002 | CA2428055A1 Process for the preparation of latent antithrombin iii |
| 05/16/2002 | CA2427757A1 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | CA2426730A1 Calcilytic compounds |
| 05/16/2002 | CA2426716A1 Acid derivatives useful as serine protease inhibitors |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
| 05/15/2002 | EP1205475A1 Flavonoid compounds for use against oxidative stress and UV radiation |
| 05/15/2002 | EP1205181A2 Composition and method for parenteral administration of ibuprofen D, L-or L-Lysine salt |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204646A1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/15/2002 | EP1204640A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
| 05/15/2002 | EP1204426A2 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 05/15/2002 | EP1204407A2 Implantable active ingredient depot |
| 05/15/2002 | EP1167360A9 Human chymase inhibitors |
| 05/15/2002 | EP1071745A4 Process for synthesizing cox-2 inhibitors |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | EP0730443B1 Suspension of loteprednol etabonate |
| 05/15/2002 | CN1349542A Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 05/15/2002 | CN1349533A Heteroaryl diazabicycloalkanes, their prepn. and use |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349504A Piperidine derivatives useful as CCR5 antagonists |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1349423A Composition comprising tramadol aterial and a selective cox-2 inhibitor drug |
| 05/15/2002 | CN1349410A Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 05/15/2002 | CN1348806A Externally applied Chinese medicine ointment for treating malignant boil, furuncle, carbuncle and paronychia |
| 05/15/2002 | CN1348796A Pain treating composite medicine |
| 05/15/2002 | CN1348787A Chinese medicine prepn for treating lupus erythematosus |
| 05/15/2002 | CN1348773A Chinese medicine navel melted tablet for treating menalgia and its prepn |
| 05/15/2002 | CN1348771A Active animal protein liquid and its application |
| 05/15/2002 | CN1348768A 活性山羊血粉胶囊 Activity goat blood meal capsule |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084744C N-substituted azaheterocyclic compounds |
| 05/15/2002 | CN1084740C Angiogensis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 05/15/2002 | CN1084621C 4,4-disubstituted (cyclohexan-1-ols-monomers and related compounds |
| 05/15/2002 | CN1084616C Coatings for tablet of paracetamol and domperidone |
| 05/14/2002 | US6388047 Hydrophobic, hydrophilic macromolecules |
| 05/14/2002 | US6387953 Inhibition of TNF-(α)-initiated neutrophil response |
| 05/14/2002 | US6387947 Mixture containing ferulic acid; topical applying |
| 05/14/2002 | US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 05/14/2002 | US6387932 Somatostatin agonists |
| 05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/14/2002 | US6387918 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387906 Dermatophytes |
| 05/14/2002 | US6387899 Antiserotonine agents; antidepressants |
| 05/14/2002 | US6387898 Treatment for CNS injuries |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
| 05/14/2002 | US6387658 PCNA-associated cell cycle proteins, compositions and methods of use |
| 05/14/2002 | US6387416 Anti-Inflammatory herbal composition and method of use |
| 05/14/2002 | US6387383 Topical low-viscosity gel composition |
| 05/14/2002 | US6387364 Methods of healing wounds and fibrotic disorders using IL-10 |
| 05/14/2002 | CA2361160A1 Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt |
| 05/14/2002 | CA2260898C Phosphinate based inhibitors of matrix metalloproteases |
| 05/14/2002 | CA2251991C Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 05/14/2002 | CA2202030C Method for reducing unwanted cellular adhesions |
| 05/14/2002 | CA2150162C New n-pyridyl carboxamides and derivatives thereof, preparation processes thereof and pharmaceutical compositions containing thereof |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002036599A1 Thieno[2,3-c]isoquinolines for use as inhibitors of parp |
| 05/10/2002 | WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/10/2002 | WO2002036593A1 Indole derivatives as pde5-inhibitors |
| 05/10/2002 | WO2002036590A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 05/10/2002 | WO2002036587A2 Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
| 05/10/2002 | WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |